This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Physicians Interactive CEO Looks for Acquisitions

NEW YORK (The Deal) -- As doctors increasingly try to reduce their costs, leading to interest in healthcare information companies, Physicians Interactive, backed by the venture capital arm of Merck  (MRK - Get Report) has plans to pursue acquisitions to expand its geographic reach and its product offerings with an eye towards completing a deal by the end of this year, according to the CEO and founder.

"The acquisition strategy right now is two-fold," said Donato Tramuto, the CEO of Physicians Interactive, a technology company linking physicians, patients and pharmaceutical companies through mobile and online healthcare applications, by phone. "We want to continue to expand the physician database domestically but I also want to go global. We also want to figure out and smoke out more of these small startup companies that have great innovation but may not have the scale to gain the users they want."

Based in Reading, Mass., with offices in Libertyville Ill., Mumbai, Paris and San Francisco, Physicians Interactive said June 25 that it had acquired MedHelp, an online health community and health application site, for undisclosed terms. Following the acquisition, Physicians Interactive's employee base will increase to 400 or so from about 300 people now across its various offices.

"MedHelp really boosts our exposure to customers and gives us a platform to grow the consumer-facing business," Tramuto said, adding that the company will look to integrate its physician- and consumer-facing units by the end of the year.

Physicians Interactive traces its beginnings back to 2008 when Tramuto, along with the backing of Bethesda, Md.-based private equity firm Persues LLC, bought the company from Allscripts Healthcare Solutions (MDRX - Get Report). After years of growth, Perseus sold its share of Physicians Interactive to Merck Global Health Innovation Fund last August.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
MDRX $14.60 0.00%
MRK $59.38 0.00%
AAPL $132.54 0.00%
FB $80.54 0.00%
GOOG $540.11 0.00%

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs